HK1212677A1 - 新型抗細菌化合物 - Google Patents

新型抗細菌化合物

Info

Publication number
HK1212677A1
HK1212677A1 HK16100469.4A HK16100469A HK1212677A1 HK 1212677 A1 HK1212677 A1 HK 1212677A1 HK 16100469 A HK16100469 A HK 16100469A HK 1212677 A1 HK1212677 A1 HK 1212677A1
Authority
HK
Hong Kong
Prior art keywords
antibacterial compounds
new antibacterial
new
compounds
antibacterial
Prior art date
Application number
HK16100469.4A
Other languages
English (en)
Inventor
Jerme Emile Georges Guillemont
David Francis Alain Lanois
Magali Madeleine Simone Motte
Wendy Mia Albert Balemans
Anil Koul
Original Assignee
Janssen Sciences Ireland Uc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Sciences Ireland Uc filed Critical Janssen Sciences Ireland Uc
Publication of HK1212677A1 publication Critical patent/HK1212677A1/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/12Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains three hetero rings
    • C07D513/14Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/14Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
HK16100469.4A 2012-08-10 2016-01-18 新型抗細菌化合物 HK1212677A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP12180103 2012-08-10
PCT/EP2013/066681 WO2014023815A1 (en) 2012-08-10 2013-08-09 New antibacterial compounds

Publications (1)

Publication Number Publication Date
HK1212677A1 true HK1212677A1 (zh) 2016-06-17

Family

ID=47002583

Family Applications (1)

Application Number Title Priority Date Filing Date
HK16100469.4A HK1212677A1 (zh) 2012-08-10 2016-01-18 新型抗細菌化合物

Country Status (13)

Country Link
US (1) US9296760B2 (zh)
EP (1) EP2882739B1 (zh)
JP (1) JP6250668B2 (zh)
KR (1) KR102323876B1 (zh)
CN (1) CN104781250B (zh)
AU (1) AU2013301452B2 (zh)
BR (1) BR112015002931B1 (zh)
CA (1) CA2880262C (zh)
EA (1) EA201590331A1 (zh)
ES (1) ES2634999T3 (zh)
HK (1) HK1212677A1 (zh)
MX (1) MX363480B (zh)
WO (1) WO2014023815A1 (zh)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MA40759A (fr) 2014-09-26 2017-08-01 Pfizer Modulateurs de rorc2 de type pyrrolopyridine substitué par un méthyle et trifluorométhyle et leurs procédés d'utilisation
US11225487B2 (en) * 2017-02-17 2022-01-18 Trevena, Inc. 7-membered aza-heterocyclic containing δ-opioid receptor modulating compounds, methods of using and making the same
AU2018221148B2 (en) 2017-02-17 2022-05-05 Trevena, Inc. 5-membered aza-heterocyclic containing delta-opioid receptor modulating compounds, methods of using and making the same
KR102037494B1 (ko) 2017-12-11 2019-10-28 씨제이헬스케어 주식회사 광학활성을 갖는 피페리딘 유도체의 중간체 및 이의 제조방법
KR20190120112A (ko) 2019-10-08 2019-10-23 씨제이헬스케어 주식회사 광학활성을 갖는 피페리딘 유도체의 중간체 및 이의 제조방법

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60029235T2 (de) 1999-10-08 2007-06-14 Affinium Pharmaceuticals, Inc., Toronto Fab-i-hemmer
AU1192501A (en) 1999-10-08 2001-04-23 Smithkline Beecham Corporation Fab i inhibitors
ATE285821T1 (de) 1999-10-08 2005-01-15 Affinium Pharm Inc Fab i inhibitoren
CA2444597A1 (en) 2001-04-06 2002-10-06 Affinium Pharmaceuticals, Inc. Fab i inhibitors
KR101299399B1 (ko) * 2004-06-04 2013-08-22 아피늄 파마슈티컬스, 인크. 치료제, 및 그의 제조 및 사용 방법
US7973060B2 (en) 2005-10-13 2011-07-05 Crystalgenomics, Inc. Fab I inhibitor and process for preparing same
JP2009091251A (ja) * 2006-01-30 2009-04-30 Meiji Seika Kaisha Ltd 新規FabKおよびFabI/K阻害剤とその製造法
EP3255045A1 (en) * 2007-02-16 2017-12-13 Debiopharm International SA Salts, prodrugs and polymorphs of fab i inhibitors
EP2501693B1 (en) * 2009-11-18 2014-09-17 FAB Pharma SAS Aza heterocyclic acrylamides and their use as bactericides
MY165902A (en) * 2011-12-02 2018-05-18 Aurigene Discovery Tech Ltd Substituted pyridine derivatives as fabi inhibitors

Also Published As

Publication number Publication date
KR20150042801A (ko) 2015-04-21
AU2013301452A1 (en) 2015-02-05
CN104781250B (zh) 2017-05-10
KR102323876B1 (ko) 2021-11-09
BR112015002931B1 (pt) 2019-10-29
AU2013301452B2 (en) 2017-06-01
MX363480B (es) 2019-03-22
WO2014023815A1 (en) 2014-02-13
CA2880262A1 (en) 2014-02-13
BR112015002931A2 (pt) 2017-08-08
EP2882739A1 (en) 2015-06-17
MX2015001835A (es) 2015-09-29
EA201590331A1 (ru) 2016-05-31
EP2882739B1 (en) 2017-05-03
ES2634999T3 (es) 2017-10-02
CA2880262C (en) 2021-11-16
JP2015524463A (ja) 2015-08-24
JP6250668B2 (ja) 2017-12-20
US20150225424A1 (en) 2015-08-13
CN104781250A (zh) 2015-07-15
US9296760B2 (en) 2016-03-29

Similar Documents

Publication Publication Date Title
HRP20181889T1 (hr) Spojevi tetrahidropirazolopirimidina
HK1245780B (zh) 咪唑並吡咯烷酮化合物
EP2925129A4 (en) PRO-NEUROGENIC COMPOUNDS
GB201209138D0 (en) Compounds
GB201214750D0 (en) Compounds
GB201215357D0 (en) Compounds
EP2887803A4 (en) PRO-NEUROGENIC COMPOUNDS
HK1206726A1 (zh) 咪唑並三嗪酮化合物
HK1206031A1 (zh) 抗菌化合物
GB201204985D0 (en) Compounds
GB201204125D0 (en) Compounds
EP2763539A4 (en) ANTIBACTERIAL COMPOUNDS
HK1211283A1 (zh) 化合物
HK1212677A1 (zh) 新型抗細菌化合物
GB201209096D0 (en) Compounds
GB201219820D0 (en) Compounds
GB201217310D0 (en) Compounds
HK1210954A1 (zh) 抗細菌化合物
GB201211202D0 (en) Antimicrobial compounds
IL239207A0 (en) Antibacterial compounds
GB201211203D0 (en) Antimicrobial compounds
GB201219690D0 (en) New compounds l
GB201220684D0 (en) New compounds
GB201215368D0 (en) New compounds
GB201215370D0 (en) New compounds

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20230809